Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.4K Buy
548
+2
+0.4% +$234 0.05% 76
2026
Q1
$65.7K Buy
546
+4
+0.7% +$462 0.05% 77
2025
Q4
$57.1K Buy
542
+45
+9% +$4.22K 0.04% 83
2025
Q3
$41.7K Buy
+497
New +$40.9K 0.03% 98

Other funds holding MRK

Seneschal Advisors's MRK Position: Q2 2026 in Review

Seneschal Advisors increased its Merck (MRK) stake by 0.37% in Q2 2026, buying an estimated $234 and bringing the position to 548 shares worth $70.4K. The position accounts for 0.05% of the portfolio, ranked #76.

Seneschal Advisors first reported a position in MRK in Q3 2025 and has held it in 4 quarters since. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Seneschal Advisors held 548 shares of Merck worth $70.4K as of Q2 2026.
  • Seneschal Advisors bought 2 Merck shares in Q2 2026, an estimated $234.
  • Merck made up 0.05% of Seneschal Advisors's portfolio in Q2 2026, its #76 holding.
  • Seneschal Advisors first reported a position in Merck in Q3 2025 and has held it in 4 quarters since.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Seneschal Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.